BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22929411)

  • 1. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
    Shimizu M; Kuroda M; Sakashita N; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Ohta K; Taniguchi T; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
    Cytokine; 2012 Dec; 60(3):694-700. PubMed ID: 22929411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
    Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
    J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.
    Kuroda M; Shimizu M; Inoue N; Ikeno I; Nakagawa H; Yokoi A; Niida Y; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
    Neurochem Int; 2015; 85-86():24-30. PubMed ID: 25895963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
    Shimizu M; Kuroda M; Inoue N; Konishi M; Igarashi N; Taneichi H; Kanegane H; Ito M; Saito S; Yachie A
    Cytokine; 2014 Mar; 66(1):1-6. PubMed ID: 24548418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
    Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
    Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.
    Piercefield EW; Bradley KK; Coffman RL; Mallonee SM
    Arch Intern Med; 2010 Oct; 170(18):1656-63. PubMed ID: 20937925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
    Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
    Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
    Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
    Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS.
    Shimizu M
    Pediatr Int; 2020 Mar; 62(3):308-315. PubMed ID: 31742829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of thrombomodulin and tumor necrosis factor-alpha levels in patients with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection].
    Yamamoto T; Isokawa S; Miyata H; Yoshioka K
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):60-4. PubMed ID: 10361420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Shimizu M; Inoue N; Kuroda M; Mizuta M; Sugimoto N; Kaneda H; Ohta K; Yachie A
    Clin Exp Nephrol; 2017 Feb; 21(1):76-82. PubMed ID: 26945868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
    Shimizu M; Inoue N; Kuroda M; Irabu H; Takakura M; Kaneda H; Sugimoto N; Ohta K; Yachie A
    Clin Exp Nephrol; 2017 Dec; 21(6):1083-1087. PubMed ID: 28283851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues.
    Westerholt S; Hartung T; Tollens M; Güstrau A; Oberhoffer M; Karch H; Klare B; Pfeffer K; Emmrich P; Oberhoffer R
    Cytokine; 2000 Jun; 12(6):822-7. PubMed ID: 10843773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111.
    Matano S; Inamura K; Konishi M; Okumura T; Kawai H; Okamura T; Takata Y; Yamada K; Obata M; Nagata H; Muramoto Y; Sugimoto T
    J Infect Chemother; 2012 Aug; 18(4):558-64. PubMed ID: 22080202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F; Sölder B; Caprioli A; Karch H
    Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel marker of development of HUS associated with enterohemorrhagic Escherichia coli infection--thrombomodulin levels in the blood].
    Nagayama K
    Nihon Rinsho; 1997 Mar; 55(3):747-50. PubMed ID: 9086792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.